This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.89% per year. These returns cover a period from January 1, 1988 through March 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Microcap Article: Archive
Natural Health Stock Declines Following Lower Q4 Earnings
by Zacks Equity Research
NHTC reports mixed fourth-quarter 2024 results with steady revenues amid challenges in key markets. New product launches drive optimism for growth.
NHTCPositive Net Change
consumer-discretionary earnings
GEOS Stock Declines Despite Q1 Earnings Uptick Y/Y, Gross Margin Down
by Zacks Equity Research
Geospace reports a revenue decline and mixed segment performance in first-quarter fiscal 2025, while Smart Water segment shows strong growth.
GEOSNegative Net Change
earnings electronics tech-stocks
Zacks Initiates Coverage of bioAffinity With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates bioAffinity as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore BIAF's promising growth prospects and financial health amid market challenges.
BIAFNegative Net Change
biotechnology biotechs medical
KOSS Stock Down 2% Despite Posting Q2 Earnings on Solid European Sales
by Zacks Equity Research
Koss reports Q2 earnings on strong European sales and DTC growth, with revenue up 5.9%, but faces headwinds from rising freight costs.
KOSSPositive Net Change
consumer-discretionary earnings
GSI Technology Incurs Loss in Q3, Narrows Y/Y on Lower Costs
by Zacks Equity Research
GSIT posts Q3 loss amid Nokia sales decline and lower SigmaQuad shipments while focusing on AI and defense contracts for growth.
GSITNo Net Change
computers earnings tech-stocks
Zacks Initiates Coverage of DallasNews With Neutral Recommendation
by Debasmita Chatterjee
Discover why Zacks has issued a "Neutral" rating for DallasNews, being the first on Wall Street to initiate coverage of the stock. Explore the company's digital shift, cost-cutting moves and subscriber growth, balanced against declining print revenues and ad struggles.
DALNPositive Net Change
consumer-staples
Utah Medical's EPS Declines 27% Y/Y in Q4, Stock Drops 5%
by Zacks Equity Research
UTMD's Q4 EPS drops 27.4% year over year, and revenues fall 25.8% on weak PendoTECH sales. Revenues are expected to decline further in 2025.
UTMDPositive Net Change
earnings medical
National Research's Q4 Earnings Drop Y/Y, Stock Falls 9%
by Zacks Equity Research
NRC's Q4 EPS drops to 28 cents despite revenue growth, hit by rising costs and higher interest expenses.
NRCPositive Net Change
business-services earnings
Zacks Initiates Coverage of Crawford United With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates Crawford United as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore CRAWA's promising growth prospects and financial health amid market challenges.
CRAWANegative Net Change
industrial-products
Zacks Initiates Coverage of Cemtrex With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates Cemtrex as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore CETX's promising growth prospects and financial health amid market challenges.
CETXNegative Net Change
electronics tech-stocks
NVE Corp's Stock Declines 16% Following Its Q3 Earnings Release
by Zacks Equity Research
Despite a 25% year-over-year revenue drop in the third quarter of fiscal 2025, NVEC holds $5.49 million in cash and remains debt-free, signaling strong financial discipline.
NVECPositive Net Change
earnings tech-stocks
Is PrimeEnergy Still Worth Buying After Surging 82% in 6 Months?
by Zacks Equity Research
PNRG's focus on horizontal drilling in West Texas boosts production rates and accelerates returns, aligning with industry trends to enhance resource recovery.
APANegative Net Change FANGNegative Net Change PNRGNegative Net Change
energy oil-energy
AMCON's Q1 EPS Drops Y/Y Amid Rising Costs, Shares Down 5%
by Zacks Equity Research
DIT's Q1 EPS falls to 57 cents despite 10.3% revenue growth, impacted by rising costs and higher interest expenses. Strategic acquisitions drive growth.
DITNegative Net Change
earnings retail
RMCF Stock Falls Despite Q3 Earnings Improvement, Margin Declines
by Zacks Equity Research
Rocky Mountain's third-quarter fiscal 2025 results are affected as rising costs pressure margins. Revenue grows, but operational challenges persist.
RMCFNegative Net Change
earnings restaurants retail
Hurco Stock Down on Q4 Loss, Revenue and Gross Margins Decline
by Zacks Equity Research
HURC posts a quarterly loss and revenue dip in fourth-quarter fiscal 2024, with declining margins and weak demand.
HURCPositive Net Change
earnings industrial-products
AXIL Brands Earnings Surge Y/Y in Q2, Cash Position Improves
by Zacks Equity Research
AXIL posts y/y earnings growth, with dips in revenues and profits in Q2. Yet, a stronger cash position and growth initiatives offer optimism.
AXILNegative Net Change
consumer-staples earnings
Taylor Devices Q2 Earnings Fall 39% Y/Y, Shares Drop 2%
by Zacks Equity Research
TAYD reports a drop in EPS during the fiscal second quarter as lower sales weigh, but strong backlog growth hints at recovery opportunities in key markets.
TAYDPositive Net Change
earnings industrial-products
ENSV Posts Y/Y Q3 Earnings & Revenue Growth Despite Looming Challenges
by Zacks Equity Research
Enservco's Y/Y revenue growth in Q3 is driven by logistics and a narrower y/y loss despite challenges in production services and rising costs.
ENSVNegative Net Change
earnings energy oil-energy
Daily Journal 2024 Earnings Up Y/Y, Journal Technologies Unit Aids
by Zacks Equity Research
DJCO reports strong FY 2024 results, with net income per share surging to $56.73, driven by Journal Technologies' revenue growth and marketable securities gains.
DJCOPositive Net Change
consumer-staples earnings
Flanigan's Stock Falls Following Earnings Decline in Fiscal 2024
by Zacks Equity Research
BDL reports strong revenue growth in fiscal 2024, driven by restaurant and retail sales, despite challenges to profitability.
BDLNo Net Change
earnings restaurants retail
Perma-Pipe Stock Up 13% Since Q3 Earnings Rise Y/Y Amid Backlog Growth
by Zacks Equity Research
PPIH reports strong Q3 earnings with growing backlog and improved profitability, overcoming a 9% decline in net sales.
PPIHNegative Net Change
earnings industrial-products
SigmaTron Stock Up 3% Despite Incurring Q2 Loss on Supply Chain Issues
by Zacks Equity Research
SGMA incurs a loss of $1.55 per share in the second quarter of fiscal 2025 amid revenue decline and supply chain challenges but highlights strategic moves for recovery and future growth.
SGMAPositive Net Change
computers earnings tech-stocks
Zacks Initiates Coverage of Better Choice With Neutral Recommendation
by Debasmita Chatterjee
Discover why Zacks has given a "Neutral" rating for Better Choice, being the first on Wall Street to initiate coverage on the stock. Dive into the company's profitability milestone and international growth, balanced by challenges in liquidity.
retail
Optex Systems Stock Declines Despite Y/Y Earnings Growth in 2024
by Zacks Equity Research
OPXS reports 62% year-over-year earnings growth in fiscal 2024, driven by strong military demand and margin expansion.
OPXSNegative Net Change
aerospace earnings
CSP Posts Q4 Loss as Revenues Decline Y/Y, Focuses on Growth in 2025
by Zacks Equity Research
CSPI reports a Q4 loss due to decreased revenues but emphasizes growth in recurring revenue and strategic investments to support a stronger outlook for 2025.
CSPINegative Net Change
earnings tech-stocks